We retrospectively reviewed the women's choice on further testing after a positive conventional aneuploidy screening in our centre from August 2010 to July 2014. HBsAg status was checked routinely in all pregnant women. All women with a positive aneuploidy screening result were counselled by maternal fetal medicine team. With the use of descriptive statistics and Chi-square test, we compared their choice between HBsAg-positive and -negative women.
Objectives:
To investigate the value of diagnosis in fetal neural tube defects(NTDs) by ultrasound during the first trimester, according to the analysis of relative standard ultrasonic views and features of NTDs in the early pregnancy. Methods: In total, 83 pregnant women were collected if they had taken the prenatal ultrasound screening and were diagnosed to have a NTDs baby, and all the ultrasound images enrolled would be read to analysis the relevant ultrasonic views and features, and then estimated the value of diagnosis in fetal NTDs by ultrasound during the first trimester. Results: The total number of people enrolled was 83, including 63 people (63/83) diagnosed in the first trimester, including cases of nencephaly/exencephaly were 37, encephalocele were 6, holoprosencephaly were 13, hydrocephaly were 4, spina bifida were 3, and all cases had been proved. 20 cases (20/83) were diagnosed after 15 gestational weeks, including cases of holoprosencephaly (n=1), hydrocephaly (n=12), encephalocele (n=1), spina bifida (n=6). The early pregnancy detection rate of fetal NTDs was 75.90% (63/83) by ultrasound, and nencephaly/exencephaly was 100% (37/37), encephalocele was 85.71% (6/7), spina bifida was 33.33% (3/9, holoprosencephaly was 92.85% (13/14). Conclusions: Early pregnancy ultrasound has highly value in the diagnosis of fetal NTDs. The integrity of skull, ''butterfly signs'' of choroid plexus and the continuity of spine were all important ultrasonic screening content for NTDs fetuses, while the cerebral cross-sections and spinal sagittal section were fairly significant relative ultrasonic views.
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Objectives: In the NIPT era, the importance of first trimester combined test is reducing. But for the detection of Trisomy 13 (T13), it is still useful because detection rate and positive predictive value of it by NIPT is rather lower than Trisomy 21 and 18. The aim of our study is to examine sonographic findings in fetuses with T13 in the first trimester of pregnancy. Methods: Sonographic findings of 8 cases of T13 which were diagnosed in our clinic were reviewed. Common and characteristic findings were chosen. Results: The most common findings in T13 was increased Nuchal translucency (NT) thickness which was found in 7 out of 8 cases and the second common findings was tachycardia which was found in 6 out of 8 cases. Five cases had unbalanced structure in four chamber heart and 4 cases had reversed ductus venosus (DV) flow. Single umbilical artery and mild pyelectasis were also common when these findings were investigated. Polydactyly was unsure in many cases. Facial features varied in these cases and hypotelorism or cyclopia were not always detected. Holoprosencephaly, especially with typical alober type was not so common as expected. We found one atypical case which had normal NT, normocardia, normal facial features and normal intracranial findings. Reversed DV flow, pyelectasis and abnormal serum marker values were of assistance to detection. Conclusions: Sonographic features in T13 vary from case to case. Typical alober holoprosencephaly is not common. Detecting T13 by first trimester ultrasound may rely on tachycardia rather than cranial or facial features. Serum markers are still valuable for the detection of T13.
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First trimester prenatal diagnosis of aberrant right subclavian artery
MC ''Markovs'', Sofia, Bulgaria
Objectives: To assess the possibilities of first trimester prenatal diagnosis of aberrant right subclavian artery (ARSA). Methods: A prospective study of 283 singleton pregnancies scanned between 11-13+6 weeks of gestation (w.g.) was performed in MC ''Markovs'', Sofia between Jun 2015 and Feb 2016. All cases were examined in B-mode and ultrasound screening for fetal abnormalities was performed according to standard published guidelines. In addition, the natural course of the right subclavian artery (RSA) was also identified by Colour Doppler. All continuing pregnancies were followed-up by ultrasound in the second trimester. No false-positive or false-negative cases of ARSA were found. Results: Overall 5 cases of ARSA were detected in the first trimester throughout the study period. In 4 of them ARSA was an isolated finding. In the last case the nuchal translucency was also increased. Fetal karyotyping revealed an associated Trisomy 21 and the parents opted for termination of pregnancy. Conclusions: Visualisation of RSA is relatively easy during the 11-13+6 w.g. scan. Since the association between ARSA and chromosomal fetal abnormalities is well established, the implementation of its sonographic evaluation might improve the sensitivity of the first trimester screening. Objectives: The objective is to present the no call rate using SNP based NIPT (Panorama test Natera) in a single private hospital and to compare it with the existing published data. Methods: We registered all the cases of NIPT performed in our institution since 2013, all the tests are performed after having had a ultrasonography to date the pregnancy and rule out the possibility of vanishing twin. The use of NiPT in our setting is usually after the combined first trimester screening in a contingent manner. The cost of the test is covered by the patient. In cases of no call at first draw we offer a redraw in all cases except if the laboratory say so. Results: We have performed 1662 Panorama tests during the study period. In 26 cases (1,5 %) we had a no call result at first draw. In these group a second redraw was taken and was successful in the 74% of the cases yielding a proportion of definitive no call of 0,4%. Those cases with no result were either very low fetal fraction (2 cases) with normal combined screening, impossibility of obtain a DNA pattern (1 cases) that finally was a tetrasomy 18p, one suspicion of mosaicism 45X/46XX (normal karyotipe) and a overlooked vanishing twin.
From the aneuploidy screening there was no case of either Trisomy 21, 18 or 13, however the tetrasomy 18 p might be considered in the spectrum of Trisomy 18. Conclusions: Our no call rate using a SNP based test, Panorama, is lower in comparison with the available evidence from the laboratory, their more recent publication quotes a no call rate of 2,8 %. In our setting after redraw we have a 0,4 % no call rate. These results may be related to the fact of performing an early scan to rule out twins and to date the pregnancy. On the other hand the BMI of our population is lower compared with other countries, that's probably one of the reasons of having a higher fetal fraction that allows to report a result.
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Performance of the 13-week gross-anatomy survey in a primary care centre in the Netherlands Objectives: To determine the percentage of fetal congenital abnormalities detected at the 13-week gross-anatomy survey performed in concomitance of the dating scan or the combined test (CT) in an ultrasound primary care centre. Methods: This is a retrospective cohort study performed in a large primary care centre in the Netherlands. Pregnancies were included in the study if an ultrasound scan was performed between 11 and 13+6 weeks of gestation and if the estimated date of delivery (EDD) was between 01-01-2012 and 01-01-2016. Pregnancies were excluded from the study if no information on the second trimester structural anomaly scan was available or if postnatal follow-up was missing. Results: 11330 pregnancies were included in the study. Of these, 6694 (59.1%) received a CT and 4636 (40.9%) were dating scans. Out of all 11330 pregnancies, 73 (0.6%) showed chromosomal and 103 (1.0%) structural abnormalities. 29% (N=30) of all structural abnormalities were already detected during the first trimester, including all cases of the following: anencephaly (N=4), encephalocele (N=1), exomphalos (N=9), megacystis (N=2), missing foot (N=1) and missing kidney (N=1). Detection rate for gastroschisis was 67% (N=2), while heart abnormalities were detected in the first trimester in only 14% of cases (N=3). Conclusions: In a primary care setting where a gross anatomy survey is performed in concomitance of the CT or dating scan, one third of structural anomalies can already be detected in the first trimester. These mostly involve very severe abnormalities, while less severe anomalies are still mostly detected in the second trimester. With further training, more time allocated to the ultrasound examination and the performance of a systemic anatomy survey the detection rate could further increase.
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Why do patients refuse invasive prenatal testing? P. Sadlecki, M. Walentowicz-Sadlecka, P. Walentowicz, M. Grabiec
Department of Obstetrics and Gynecology Nicolaus Copernicus University, Bydgoszcz, Poland
Objectives: The most commonly performed prenatal invasive diagnostic procedure is second trimester amniocentesis. In recent years, determination of personalised risk for fetal chromosomal anomalies emerged as an important component of prenatal genetic counselling. Women in whom fetal risk for chromosomal aberrations is elevated are offered further testing. The aim of this study was to identify factors that may influence the decision to refuse invasive prenatal testing aimed at determination of fetal karyotype in a group of patients at increased risk of Trisomy 21. Methods: The analysis included 177 patients with singleton pregnancy, whose personalised risk score for Trisomy 21 calculated on the basis of the combined test exceeded 1:300. The following factors were analysed as potential determinants of the decision to refuse amniocentesis: maternal age (≥35 years), gravidity, number of miscarriages in previous pregnancies, educational status, marital status, indications to prenatal testing, gestational age at the time of prenatal testing, personalised risk score for fetal chromosomal aberrations and NT value. Results: A statistically significant relationship was found between the decision to refuse amniocentesis and the number of previous miscarriages, maternal educational level, NT values and personalised risk score for fetal chromosomal aberrations. Women with personalised risk scores for Trisomy 21 greater than 1:100 opted out of invasive prenatal diagnosis significantly less often than the remaining participants. Conclusions: In conclusion, the key role of high quality and accuracy of non-invasive diagnostic tests conducted in the first trimester should be emphasised as personalised risk score for fetal chromosomal aberrations determined based on their results is pivotal for further management of pregnancy. Equally important is to provide the patients with an accurate and comprehensible information about potential benefits and risks of invasive testing.
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